PRVIX (PRVIX) Stock Price & Analysis
PRVIX (PRVIX) rose 0.53% to USD 59.22 as of June 10, 2026 at 05:09 UTC, according to Nexqual real-time market data.
PRVIX last closed at USD 58.91; the session ranged USD 59.22–59.22 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 50.11–60.05 (NAS). Source: Nexqual, June 10, 2026 at 05:09 UTC.
Key Statistics (as of June 10, 2026 at 05:09 UTC)
| Price | USD 59.22 |
|---|---|
| Change | ▲ 0.53% (up) |
| Previous Close | USD 58.91 |
| Open | USD 59.22 |
| Day Range | USD 59.22 – 59.22 |
| 52-Week Range | USD 50.11 – 60.05 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRVIX)
Nexqual's technical model rates PRVIX "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 05:09 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.38 (neutral) |
| vs SMA50 | Above (USD 57.37) |
| MACD | 0.52 (positive) |
Financial Health Score (PRVIX)
Nexqual rates PRVIX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:09 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRMIX | T. Rowe Price Mid-Cap Value Fun | USD 36.8 | ▲ 1.02% |
| RPTIX | T. Rowe Price Mid-Cap Growth Fu | USD 99.16 | ▲ 0.97% |
| REIPX | T. Rowe Price Equity Income Fun | USD 43.02 | ▲ 0.63% |
| TRAIX | T. Rowe Price Capital Appreciat | USD 37.25 | ▲ 0.19% |
| THISX | T. Rowe Price Health Sciences F | USD 83.07 | ▲ 1.39% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:09 UTC. This page is informational and not investment advice.